AL Amyloidosis - 146 Studies Found

Active, not recruiting : Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
:
  • Primary Systemic Amyloidosis
  • Light Chain Deposition Disease : 2007-08-24
    :
    • Drug: bortezomib Bortezomib 1.
Not yet recruiting : A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis
: Amyloidosis
: 2015-08-27
:
  • Drug: Carfilzomib Lyophilized

Terminated : Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis
: Primary Systemic Amyloidosis
: 2002-02-14
:
  • Drug: 4'-iodo-4'-deoxydoxorubicin

Active, not recruiting : Study of Oral IXAZOMIB in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
: Light-Chain Amyloidosis
: 2011-03-15
: Drug: MLN9708 Patients will receive escalating doses of MLN9708 orally on Days 1, 8 and 15 of a 28-day c
Completed : Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed
: Primary Systemic Amyloidosis
: 2010-07-26
:
  • Drug: Lenalidomide Lenalidomid
Completed : Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis
: Primary Systemic Amyloidosis
: 2010-02-17
:
  • Drug: bortezomib 1.3 mg/m^2, b
Completed : Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis
: Amyloidosis
: 2013-11-15
:
  • Drug: Bortezomib Other Name: V
Terminated : Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis
: Myeloma
: 2013-03-06
:
  • Drug: Pomalidomide

Recruiting : A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early
:
  • Plasma Cell Dyscrasia
  • Monoclonal Gammopathy

: 2016-04-11
Completed : A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis
:
  • Leukemia
  • Amyloidosis

: 2009-04-28
:
  • Drug: Lenalidomide

<<< Previous | Next >>>